nerve regeneration program (Migragen)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namenerve regeneration program (Migragen)
Drug Alias NameC3-C2IN/C2II (Migragen)RGM proteins (Migragen)PROGO (Migragen)PROGO-I (Migragen)repulsive guidance molecules (Migragen) +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsTrauma, Nervous SystemSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMigragen AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMigragen AG
Active IndicationsN/A
Inactive IndicationsTrauma, Nervous SystemSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksN/A